# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin miceAddit...
HC Wainwright & Co. analyst Emily Bodnar reiterates Sana Biotechnology (NASDAQ:SANA) with a Buy and maintains $12 price ...
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This ...
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.
- SEC Filing
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.
JMP Securities analyst Reni Benjamin maintains Sana Biotechnology (NASDAQ:SANA) with a Market Outperform and raises the pric...
U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.